
Thale Dawn Patrick-Brown
- Clinical Trial Manager; MSc, MIET
Thale has a varied background, and joined OUH after working in public sector research environments in the UK, Norway and Canada. She holds degrees from the University of Reading (MSc) and the University of Lethbridge (BSc), and is a PhD Student at Heriot-Watt University in Edinburgh, Scotland.
Thale's main research focus is currently epidemiology and pandemic response under the SARS CoV-2 pandemic.
- The EU-SolidAct pan-European platform for pandemic research and preparedness
- European Research and Preparedness Network for Pandemics and Emerging Infectious Diseases (EU-RESPONSE)
- EuroPMP - European Action on Pseudomyxoma peritonei (via COST)
Publications 2023
Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial
Crit Care, 27 (1), 9
DOI 10.1186/s13054-022-04205-8, PubMed 36627655
Publications 2020
Estimating the Prevalence of Pseudomyxoma Peritonei in Europe Using a Novel Statistical Method
Ann Surg Oncol, 28 (1), 252-257
DOI 10.1245/s10434-020-08655-8, PubMed 32488520
Publications 2019
Sex-related differences in primary metastatic site in rectal cancer; associated with hemodynamic factors?
Clin Transl Radiat Oncol, 21, 5-10
DOI 10.1016/j.ctro.2019.11.006, PubMed 31872084